share_log

Truist Financial Cuts Teleflex (NYSE:TFX) Price Target to $241.00

Truist Financial Cuts Teleflex (NYSE:TFX) Price Target to $241.00

Truist Financial将Teleflex(纽约证券交易所代码:TFX)目标价下调至241.00美元
kopsource ·  2022/09/22 09:41

Teleflex (NYSE:TFX – Get Rating) had its target price dropped by investment analysts at Truist Financial from $265.00 to $241.00 in a report released on Thursday, The Fly reports. Truist Financial's price target points to a potential upside of 12.52% from the stock's current price.

据The Fly报道,在周四发布的一份报告中,Truist Financial的投资分析师将Teleflex(纽约证券交易所代码:TFX-GET评级)的目标价从265.00美元下调至241.00美元。Truist Financial的目标价显示,该股较当前股价有12.52%的潜在上涨空间。

A number of other brokerages have also commented on TFX. Piper Sandler reduced their target price on shares of Teleflex from $295.00 to $265.00 in a research report on Thursday, July 28th. Wolfe Research assumed coverage on shares of Teleflex in a research report on Tuesday, July 5th. They set an "outperform" rating and a $300.00 target price on the stock. Wells Fargo & Company lowered shares of Teleflex from an "overweight" rating to an "equal weight" rating and set a $248.00 target price on the stock. in a research report on Friday, July 29th. Morgan Stanley dropped their price objective on shares of Teleflex from $300.00 to $278.00 and set an "equal weight" rating on the stock in a research note on Friday, July 29th. Finally, StockNews.com downgraded shares of Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, July 29th. Six analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $322.70.

其他一些券商也对TFX发表了评论。派珀·桑德勒在7月28日星期四的一份研究报告中将Teleflex的股票目标价从295.00美元下调至265.00美元。Wolfe Research在7月5日星期二的一份研究报告中对Teleflex的股票进行了报道。他们为该股设定了“跑赢大盘”的评级和300.00美元的目标价。富国银行将Teleflex的股票评级从增持下调至持平,并为该股设定了248.00美元的目标价。在7月29日星期五的一份研究报告中。摩根士丹利在7月29日星期五的一份研究报告中将Teleflex的目标股价从300.00美元下调至278.00美元,并对该股设定了“同等权重”的评级。最后,在7月29日星期五的一份研究报告中,StockNews.com将Teleflex的股票评级从买入下调至持有。六位分析师对该股的评级为持有,五位分析师对该股的评级为买入。根据MarketBeat.com,该公司的平均评级为持有,平均目标价为322.70美元。

Get
到达
Teleflex
Teleflex
alerts:
警报:

Teleflex Trading Down 2.7 %

Teleflex交易下跌2.7%

Shares of Teleflex stock opened at $214.19 on Thursday. The company has a market capitalization of $10.05 billion, a P/E ratio of 19.91, a P/E/G ratio of 2.17 and a beta of 1.10. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.43 and a current ratio of 2.27. The company has a fifty day moving average of $242.25 and a 200 day moving average of $279.20. Teleflex has a fifty-two week low of $213.76 and a fifty-two week high of $391.39.

周四,Teleflex的股票开盘报214.19美元。该公司市值为100.5亿美元,市盈率为19.91倍,市盈率为2.17倍,贝塔系数为1.10。该公司的负债权益比率为0.42,速动比率为1.43,流动比率为2.27。该公司的50日移动均线切入位在242.25美元,200日移动均线切入位在279.20美元。Teleflex的股价为213.76美元,为52周低点,52周高点为391.39美元。

Teleflex (NYSE:TFX – Get Rating) last released its quarterly earnings data on Thursday, July 28th. The medical technology company reported $3.39 EPS for the quarter, beating the consensus estimate of $3.34 by $0.05. Teleflex had a net margin of 18.16% and a return on equity of 16.84%. The business had revenue of $704.50 million during the quarter, compared to the consensus estimate of $719.50 million. During the same quarter in the prior year, the firm earned $3.35 EPS. The business's revenue was down 1.3% on a year-over-year basis. On average, sell-side analysts anticipate that Teleflex will post 13.13 earnings per share for the current fiscal year.
Teleflex(纽约证券交易所代码:TFX-GET Rating)上一次发布季度收益数据是在7月28日星期四。这家医疗技术公司公布本季度每股收益为3.39美元,比普遍预期的3.34美元高出0.05美元。Teleflex的净利润率为18.16%,股本回报率为16.84%。该业务本季度的收入为7.045亿美元,而普遍预期为7.195亿美元。去年同期,该公司每股收益为3.35美元。该业务的收入同比下降了1.3%。卖方分析师平均预计Teleflex本财年每股收益将达到13.13美元。

Institutional Inflows and Outflows

机构资金流入和流出

A number of institutional investors and hedge funds have recently added to or reduced their stakes in TFX. Inspire Investing LLC purchased a new stake in shares of Teleflex during the first quarter worth about $368,000. National Bank of Canada FI boosted its position in Teleflex by 7,726.3% during the first quarter. National Bank of Canada FI now owns 13,383 shares of the medical technology company's stock worth $4,633,000 after acquiring an additional 13,212 shares during the last quarter. Regentatlantic Capital LLC boosted its position in Teleflex by 2.3% during the first quarter. Regentatlantic Capital LLC now owns 2,215 shares of the medical technology company's stock worth $786,000 after acquiring an additional 50 shares during the last quarter. Procyon Advisors LLC boosted its position in Teleflex by 47.0% during the second quarter. Procyon Advisors LLC now owns 992 shares of the medical technology company's stock worth $244,000 after acquiring an additional 317 shares during the last quarter. Finally, Stanley Laman Group Ltd. boosted its position in Teleflex by 16.7% during the first quarter. Stanley Laman Group Ltd. now owns 8,940 shares of the medical technology company's stock worth $3,172,000 after acquiring an additional 1,282 shares during the last quarter. Hedge funds and other institutional investors own 95.91% of the company's stock.

一些机构投资者和对冲基金最近增持或减持了TFX的股份。Inspire Investment LLC在第一季度购买了Teleflex的新股,价值约36.8万美元。加拿大国民银行FI在第一季度将其在Teleflex的头寸增加了7726.3%。加拿大国民银行FI现在拥有这家医疗技术公司13,383股票,价值4,633,000美元,在上个季度额外购买了13,212股票。RegentAtlantic Capital LLC在第一季度将其在Teleflex的头寸增加了2.3%。RegentAtlantic Capital LLC在上个季度增持了50股后,现在拥有2215股这家医疗技术公司的股票,价值78.6万美元。Procyon Advisors LLC在第二季度将其在Teleflex的头寸增加了47.0%。Procyon Advisors LLC在上个季度增持了317股后,现在拥有992股这家医疗技术公司的股票,价值24.4万美元。最后,Stanley Laman Group Ltd.在第一季度将其在Teleflex的头寸提高了16.7%。斯坦利·拉曼集团有限公司(Stanley Laman Group Ltd.)目前持有这家医疗技术公司8,940股股票,价值3,172,000美元,该公司在上个季度又收购了1,282股。对冲基金和其他机构投资者持有该公司95.91%的股票。

About Teleflex

关于Teleflex

(Get Rating)

(获取评级)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Teleflex公司设计、开发、制造和供应一次性医疗设备,用于全球危重护理和外科应用中的常见诊断和治疗程序。它提供血管通路产品,包括Arrow品牌的导管、导管导航和尖端定位系统,以及用于静脉治疗、测量血压和通过单一穿刺点提取血液样本的骨内通路系统。

Further Reading

进一步阅读

  • Get a free copy of the StockNews.com research report on Teleflex (TFX)
  • These 3 Big Dividend Payers Also Boast Strong Price Growth
  • Natural Gas Prices Continue To Rally, These Stocks Should Benefit
  • The Worst May be Over for Target, But is the Stock Safe to Buy?
  • Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
  • Two Fun Stocks The Insiders Are Buying
  • 免费获取StockNews.com关于Teleflex的研究报告(TFX)
  • 这三大股利支付者也拥有强劲的价格增长
  • 天然气价格继续回升,这些股票应该会受益
  • 对塔吉特来说,最糟糕的时期可能已经过去,但这只股票买起来安全吗?
  • 这些液态天然气股票准备好上行了吗?
  • 内部人士正在买入的两只有趣的股票

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

接收Teleflex Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Teleflex和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发